For most patients, direct oral anticoagulants (DOACs) are preferred over vitamin K
antagonists for stroke prevention in atrial fibrillation and for venous thromboembolism …

The conjunction of atrial fibrillation (AF) and venous thromboembolism (VTE) is common in
clinical practice. Over the last 2 decades, a significant number of articles (2500) have been …

Importance Insufficient data exist about the clinical presentation, short-term, and long-term
outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in …

The benefit of rivaroxaban in thromboprophylaxis after oncologic lung surgery remains
unknown. To evaluate the efficacy and safety of rivaroxaban, patients who underwent …

Management of cancer-associated thrombosis (CAT) is usually performed employing low
molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs). Low-intensity …

It has been shown that patients with cancer have a longer expected life duration, benefiting
from advanced medical therapy. Meanwhile, the risk of suffering from cardiovascular …

One of the most important advantages of direct oral anticoagulants (DOACs) over warfarin is
that DOACs can be given in fixed doses without routine coagulation monitoring, which …

Background Data regarding uninterrupted oral anticoagulation in patients with chronic
kidney disease (CKD) during catheter ablation for left atrial arrhythmias is limited. This study …

Many patients with impaired renal function have concurrent indications for anticoagulant
therapy, including atrial fibrillation and venous thromboembolism. For mild chronic kidney …

Importance Direct-acting oral anticoagulants (DOACs) are commonly prescribed with
antiseizure medications (ASMs) due to concurrency of and the association between atrial …